| Tid | Tittel | Kategori | Vedlegg |
|---|---|---|---|
|
06.02.2026
08:30
|
EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program | - | - |
|
05.02.2026
13:19
|
EXACT Therapeutics: Correction of final warrants exercise date | - | - |
|
05.02.2026
09:17
|
EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders | INSIDEHANDEL INS |
2
|
|
05.02.2026
08:30
|
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB | INFORMASJON INF | - |
|
27.01.2026
08:00
|
EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants | INFORMASJON INF | - |
|
08.01.2026
08:30
|
EXACT Therapeutics’ Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium | - | - |
|
25.11.2025
12:57
|
EXACT Therapeutics to present company update | - |
1
|
|
24.11.2025
08:25
|
EXACT Therapeutics AS: New option program and receipt of share options by primary insiders | INSIDEHANDEL INS |
1
|